RESEARCH ARTICLE
Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
Konstantinos Tziomalos 1, Vasilios G Athyros 2, Asterios Karagiannis 2, Dimitri P Mikhailidis 1, *
1 Department of Clinical Biochemistry (Vascular Prevention Clinic) and Department of Surgery, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK
2 Second Propedeutic Department of Internal Medicine, Aristotle University, Hippokration Hospital, Thessaloniki, Greece
Article Information
Identifiers and Pagination:
Year: 2011Volume: 5
First Page: 85
Last Page: 89
Publisher ID: TOCMJ-5-85
DOI: 10.2174/1874192401105010085
Article History:
Received Date: 30/11/2010Revision Received Date: 4/1/2011
Acceptance Date: 6/1/2011
Electronic publication date: 24/2/2011
Collection year: 2011
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
Dyslipidemia is a major vascular risk factor. Interestingly, several agents used for the prevention and treatment of vascular diseases have an adverse effect on the lipid profile. In addition, agents belonging to the same class (e.g. beta blockers) can have significantly different actions on lipid levels. We summarize the effects of drugs used for the prevention and treatment of vascular diseases on the lipid profile. These effects should be considered when selecting a specific agent, particularly in high-risk patients.
Keywords:: Dyslipidemia, antihypertensive agents, antidiabetic agents, lipid-modifying agents, antiobesity agents..
